Jennifer H Martin (Jennifer Martin)

Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 62

Top Venues

British journal of clinical pharmacology

Pharmacology research & perspectives

Internal medicine journal

Cells

University of Newcastle Faculty of Health

Monash University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Newcastle Faculty of Health

Australia

Chair of Clinical Pharmacology; Head of Medicine :: School of Medicine and Public Health

University of Queensland Jan 02 2010 - Jan 02 2011

Australia

Head :: Southern Clinical School

University of Melbourne Jan 02 2005 - Jan 08 2007

Australia

Senior Lecturer :: Department of Medicine, St Vincent's Hospital

Monash University Jan 02 2000 - Jan 02 2005

Australia

Lecturer :: Preventative Medicine

Education History

Monash University - Nov 30 2006

Australia

PHD :: Clinical Pharmacology

Publications

Mathew Lozinski, Eugenie R Lumbers, Nikola A Bowden, Jennifer H Martin, Michael F Fay, Kirsty G Pringle, Paul A Tooney
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells 13 (7) (2024)
Richard J Head, Marko E Popović, Jennifer H Martin
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"? Pharmacology research & perspectives 12 (4) (2024)
Richard J Head, Marko E Popović, Jennifer H Martin
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"? Pharmacology research & perspectives 12 (4) (2024)
Mathew Lozinski, Eugenie R Lumbers, Nikola A Bowden, Jennifer H Martin, Michael F Fay, Kirsty G Pringle, Paul A Tooney
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells 13 (7) (2024)
Mathew Lozinski, Eugenie R Lumbers, Nikola A Bowden, Jennifer H Martin, Michael F Fay, Kirsty G Pringle, Paul A Tooney
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells 13 (7) (2024)
Mathew Lozinski, Eugenie R Lumbers, Nikola A Bowden, Jennifer H Martin, Michael F Fay, Kirsty G Pringle, Paul A Tooney
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells 13 (7) (2024)
Mathew Lozinski, Eugenie R Lumbers, Nikola A Bowden, Jennifer H Martin, Michael F Fay, Kirsty G Pringle, Paul A Tooney
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells 13 (7) (2024)
Jennifer H Martin, Peter Galettis, Alex Flynn, Jennifer J Schneider
Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitors. Pharmacology research & perspectives 12 (2) (2024)
Sarah Glewis, Mei Krishnasamy, Senthil Lingaratnam, Sam Harris, Craig Underhill, Chloe Georgiou, Mark Warren, Robert Campbell, Maarten IJzerman, Mussab Fagery, Ian Campbell, Jennifer H Martin, Jeanne Tie, Marliese Alexander, Michael Michael
Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey. Clinical and translational science (2023)
Michael F Jarvis, Emily Davies, Jennifer H Martin
Pharmacology Research & Perspectives: A Decade of Progress. Pharmacology research & perspectives 11 (1) (2023)
Christina Abdel Shaheed, Christopher Hayes, Christopher G Maher, Jane C Ballantyne, Martin Underwood, Andrew J McLachlan, Jennifer H Martin, Sujita W Narayan, Mark A Sidhom
Opioid analgesics for nociceptive cancer pain: A comprehensive review. CA: a cancer journal for clinicians 74 (3) (2023)
Ziqiu Tong, Lars Esser, Peter Galettis, David Rudd, Christopher D Easton, Azadeh Nilghaz, Bo Peng, Douer Zhu, Helmut Thissen, Jennifer H Martin, Nicolas Hans Voelcker
Fluoropolymer Functionalization of Organ-on-Chip Platform Increases Detection Sensitivity for Cannabinoids. Biosensors 13 (8) (2023)
Christina Abdel Shaheed, Christopher Hayes, Christopher G Maher, Jane C Ballantyne, Martin Underwood, Andrew J McLachlan, Jennifer H Martin, Sujita W Narayan, Mark A Sidhom
Opioid analgesics for nociceptive cancer pain: A comprehensive review. CA: a cancer journal for clinicians 74 (3) (2023)
Christina Abdel Shaheed, Christopher Hayes, Christopher G Maher, Jane C Ballantyne, Martin Underwood, Andrew J McLachlan, Jennifer H Martin, Sujita W Narayan, Mark A Sidhom
Opioid analgesics for nociceptive cancer pain: A comprehensive review. CA: a cancer journal for clinicians (2023)
Christina Abdel Shaheed, Christopher Hayes, Christopher G Maher, Jane C Ballantyne, Martin Underwood, Andrew J McLachlan, Jennifer H Martin, Sujita W Narayan, Mark A Sidhom
Opioid analgesics for nociceptive cancer pain: A comprehensive review. CA: a cancer journal for clinicians (2023)
Michael F Jarvis, Emily Davies, Jennifer H Martin
Pharmacology Research & Perspectives: A Decade of Progress. Pharmacology research & perspectives 11 (1) (2023)
Alicja Urbaniak, Kenneth E Thummel, Ayoade N Alade, Allan E Rettie, Bhagwat Prasad, Amedeo De Nicolò, Jennifer H Martin, David N Sheppard, Michael F Jarvis
Experimental pharmacology in precision medicine. Pharmacology research & perspectives 11 (6) (2023)
Jennifer H Martin
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19. Internal medicine journal (2023)
Bevyn Jarrott, Richard J Head, Kirsty G Pringle, Eugenie R Lumbers, Jennifer H Martin
"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacology research & perspectives 10 (1) (2022)
Kelly Lee Hayward, Vikas Bansal, Patricia Casarolli Valery, Katharine M Irvine, Penny L Wright, Caroline J Tallis, Katherine A Stuart, Neil W Cottrell, Jennifer H Martin, Elizabeth E Powell
Patient-oriented medication education intervention has long-term benefits for people with decompensated cirrhosis. Hepatology communications 6 (11) (2022)
Jennifer H Martin, Richard J Head
Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology. Pharmacology research & perspectives 10 (1) (2022)
John A Lawson, Terry O'Brien, Myfanwy Graham, Elianne Renaud, Dean Jones, Jeremy Freeman, Nicholas Lawn, Jennifer H Martin
Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience. British journal of clinical pharmacology 88 (7) (2022)
Eugenie R Lumbers, Richard Head, Gary R Smith, Sarah J Delforce, Bevyn Jarrott, Jennifer H Martin, Kirsty G Pringle
The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment. Pharmacology research & perspectives 10 (1) (2022)
Richard J Head, Eugenie R Lumbers, Bevyn Jarrott, Felix Tretter, Gary Smith, Kirsty G Pringle, Saiful Islam, Jennifer H Martin
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. Pharmacology research & perspectives 10 (1) (2022)
Jennifer H Martin, Joanne Patel
Complementary and alternative therapies in the palliative setting. Internal medicine journal 52 (10) (2022)
Jennifer H Martin, Julian Clark, Richard J Head
Buying time: Drug repurposing to treat the host in COVID-19H. Pharmacology research & perspectives 8 (4) (2021)
Wayne Hall, Jennifer H Martin
Easier patient access to medical cannabis carries risks as well as benefits. Journal of psychopharmacology (Oxford, England) 35 (11) (2021)
Saiful Islam, Shudong Wang, Nikola A Bowden, Jennifer H Martin, Richard J Head
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target. British journal of clinical pharmacology (2021)
Kelly Lee Hayward, Patricia C Valery, Preya J Patel, Catherine Li, Leigh U Horsfall, Penny L Wright, Caroline J Tallis, Katherine A Stuart, Michael David, Katharine M Irvine, Neil Cottrell, Jennifer H Martin, Elizabeth E Powell
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Jennifer H Martin, Catherine J Lucas
Reporting adverse drug events to the Therapeutic Goods Administration. Australian prescriber 44 (1) (2021)
Jennifer H Martin, Michelle Baddeley, Richard Head
Did our pharmacological strategy for COVID-19 fail? Pharmacology research & perspectives 9 (6) (2021)
Étienne Chatelut, Jeroen J M A Hendrikx, Jennifer H Martin, Joseph Ciccolini, Dirk Jan A R Moes
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology. Pharmacology research & perspectives 9 (2) (2021)
Jennifer J Schneider, Peter Galettis, Jennifer H Martin
Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine. British journal of clinical pharmacology 87 (2) (2021)
Jennifer H Martin, Richard Head
Obesity and COVID-19: Renin-Angiotensin as a mediator of morbidity and mortality. The British journal of nutrition (2021)
Kelly Lee Hayward, Patricia Casarolli Valery, PreyaJanubhai Patel, Leigh U Horsfall, Penny L Wright, Caroline J Tallis, Katherine A Stuart, Michael David, Katharine M Irvine, Neil W Cottrell, Jennifer H Martin, Elizabeth E Powell
Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis. Internal medicine journal 50 (9) (2021)
Audra de Witt, Veronica Matthews Quandamooka, Ross Stewart Bailie, Gail Garvey, Patricia Casarolli Valery, Jon Adams, Jennifer H Martin, Frances Clare Cunningham
Communication, Collaboration and Care Coordination: The Three-Point Guide to Cancer Care Provision for Aboriginal and Torres Strait Islander Australians. International journal of integrated care 20 (2) (2020)
Jennifer H Martin, Ian Olver
Precision medicine-based drug treatment individualization in oncology. British journal of clinical pharmacology 87 (2) (2020)
Jennifer H Martin
Effect of pharmaceutical regulatory policy on health impact. British journal of clinical pharmacology 86 (12) (2020)
Jennifer H Martin, Wayne Hall, Mary-Ann Fitzcharles, Laura Borgelt, Jose Crippa
Ensuring access to safe, effective, and affordable cannabis-based medicines. British journal of clinical pharmacology 86 (4) (2020)
Jennifer H Martin, Richard J Head
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19. British journal of clinical pharmacology 87 (3) (2020)
Jennifer H Martin, Nikola A Bowden
College conferences: time for merit-based selection of speakers and educators? Internal medicine journal 50 (4) (2020)
Jennifer H Martin, Nikola A Bowden
Drug repurposing in the era of COVID-19: a call for leadership and government investment. The Medical journal of Australia 212 (10) (2020)
Jennifer H Martin, Courtney Hill, Anna Walsh, Daryl Efron, Kaitlyn Taylor, Michael Kennedy, Rachel Galettis, Paul Lightfoot, Julie Hanson, Helen Irving, Meera Agar, Judith Lacey
Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience. Trials 21 (1) (2020)
Jennifer H Martin, Nicholas J Talley
Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribers. British journal of clinical pharmacology 85 (8) (2019)
Kelly Lee Hayward, Patricia Casarolli Valery, Neil W Cottrell, Katharine M Irvine, Jennifer H Martin, Elizabeth E Powell
Reply. Hepatology communications 3 (9) (2019)
Jessica Ryan, Joanne Patel, Catherine J Lucas, Jennifer H Martin
Optimal cancer drug dosing in adolescents: new issues and the old unaddressed ones. Internal medicine journal 48 (9) (2019)
Nadia Solowij, Samantha Broyd, Lisa-Marie Greenwood, Hendrika van Hell, Dave Martelozzo, Kuna Rueb, Juanita Todd, Zheng Liu, Peter Galettis, Jennifer H Martin, Robin M Murray, Alison L Jones, Patricia T Michie, Rodney J Croft
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. European archives of psychiatry and clinical neuroscience 269 (1) (2019)
Jennifer H Martin, Nikola A Bowden
DRUG REPURPOSING-Overcoming the translational hurdles to clinical use. Pharmacology research & perspectives 7 (6) (2019)
Kelly Lee Hayward, PreyaJanubhai Patel, Patricia Casarolli Valery, Leigh U Horsfall, Catherine Y Li, Penny L Wright, Caroline J Tallis, Katherine A Stuart, Katharine M Irvine, W Neil Cottrell, Jennifer H Martin, Elizabeth E Powell
Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention. Hepatology communications 3 (5) (2019)
Zheng Liu, Jeffrey Cheng, Elizabeth E Powell, Graeme Macdonald, Jonathan Fawcett, Stephen Lynch, Jennifer H Martin
Weight-based tacrolimus trough concentrations post liver transplant. Internal medicine journal 49 (1) (2019)
Daniel F B Wright, Jennifer H Martin, Jeffrey K Aronson
Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes. British journal of clinical pharmacology 85 (10) (2019)
Jennifer H Martin, Simon B Dimmitt
The rationale of dose-response curves in selecting cancer drug dosing. British journal of clinical pharmacology 85 (10) (2019)
Simon B Dimmitt, Jennifer H Martin
Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis. The Medical journal of Australia 211 (6) (2019)
Jennifer H Martin, Jennifer Schneider, Catherine J Lucas, Peter Galettis
Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction? Clinical pharmacokinetics 57 (5) (2019)
Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, Robin E Ferner
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50. British journal of clinical pharmacology 85 (10) (2019)
Catherine J Lucas, Simon B Dimmitt, Jennifer H Martin
Optimising low-dose methotrexate for rheumatoid arthritis-A review. British journal of clinical pharmacology 85 (10) (2019)
Zheng Liu, Jennifer H Martin
Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling. British journal of clinical pharmacology 84 (11) (2018)
Michael J McGee, Nicholas Whitehead, Jennifer H Martin, Nicholas Collins
Drug-associated pulmonary arterial hypertension. Clinical toxicology (Philadelphia, Pa.) 56 (9) (2018)
Kelly Lee Hayward, Leigh U Horsfall, Brittany J Ruffin, Neil W Cottrell, Veronique S Chachay, Katharine M Irvine, Jennifer H Martin, Elizabeth E Powell, Patricia Casarolli Valery
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management. Internal medicine journal 47 (8) (2018)
Laura M Dryburgh, Nanthi S Bolan, Christopher P L Grof, Peter Galettis, Jennifer J Schneider, Catherine J Lucas, Jennifer H Martin
Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British journal of clinical pharmacology 84 (11) (2018)
Nadia Solowij, Peter Galettis, Samantha J Broyd, Peter de Krey, Jennifer H Martin
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting. Drugs in R&D 18 (1) (2018)
Ian A Scott, Andrew McGavigan, Mark Ferson, Ian Woolley, Morton G Burt, Anthony Russell, Paul Bridgman, Joseph Ting, David Blacker, Yvonne Bonomo, Jennifer H Martin, Jeffrey Szer
Selected state of the art research in internal medicine, 2017. Internal medicine journal 48 (6) (2018)

Jennifer H Martin.css-eqlu8i{font-size:small;padding-left:4px;} (Jennifer Martin)

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer H Martin (Jennifer Martin)